Nestle reports sales of USD 27.1B in Q1 FY 2026

SWITZERLAND – Nestle has reported sales of US$27.05 billion (CHF 21.3 billion), a 5.7% year-on-year decrease in Q1 FY 2026, led by the infant formula recall.

Organic growth (OG) was 3.5%, which included an impact of approximately -90 bps from the infant formula recall.

In Nutrition, organic growth was -3.9%, with negative RIG, driven by infant nutrition. Food & Snacks OG was 4.2%, with RIG of 2.1%, supported by improving performance in confectionery.

Infant formula recall

In January 2026, Nestlé launched a global precautionary recall of batches of infant formula after detecting the presence of cereulide, caused by an ingredient sourced from a global industry supplier.

The recall was executed during Q1, and the focus has been on replenishing shelves to ensure parents can access the products they need.

According to the company, product availability is now back to normal. In Q1-26, the overall impact on OG was approximately -90 bps.

Philipp Navratil, Nestlé CEO, commented: “Our first-quarter performance demonstrates that our RIG-led growth strategy is delivering. Results were strong across most Zones and categories, particularly in Coffee and Food & Snacks. Building on the momentum in the first quarter, we continue to execute our strategy to deliver a stronger Nestlé.”

 Zone Americas

Organic growth was 3.8%, with RIG of 1.2% and pricing of 2.6%. OG was 1.5%, with 0.2% RIG and 1.3% pricing. In Latin America, OG was 9.1%, with 3.6% RIG and 5.5% pricing.

Reported sales were down to US$11.56 billion (CHF 9.1 billion), driven by a negative impact of 10.5% from foreign exchange movements.

Zone Asia, Oceania and Africa

Organic growth was 2.4%, with RIG of 1.1% and pricing of 1.3%. excluding Greater China, organic growth was 6.4%, with 4.6% RIG and 1.8%

In Greater China, organic growth was -10.6%, with -10.4% RIG and -0.2% pricing, as we continued to correct trade inventory and were impacted by the infant formula recall.

Reported sales were down to US$6.60 billion (CHF 5.2 billion), driven by a 10.7% negative impact from foreign exchange movements. Growth was positive across most markets, reflecting market momentum and strong execution.

Overall growth was impacted by declines in Greater China and in MENA, which was impacted by the infant formula recall and some sales disruptions due to the conflict in the region.

Zone Europe

Organic growth was 3.9%. RIG was 1.1%, up from last year. Pricing was 2.8%, moderating from 2025 levels, as we began to lap increases taken in H1-25.

Reported sales decreased to US$5.84 billion (CHF 4.6 billion), impacted by a 5.3% negative foreign exchange effect.

By market, growth trends varied. In many of our larger markets, including UK & Ireland, France and Germany, growth was held back by infant nutrition.

To receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world, SUBSCRIBE HERE.